ID   SIR2_RAT                Reviewed;         350 AA.
AC   Q5RJQ4;
DT   27-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 1.
DT   24-JUL-2024, entry version 148.
DE   RecName: Full=NAD-dependent protein deacetylase sirtuin-2;
DE            EC=2.3.1.286 {ECO:0000255|PROSITE-ProRule:PRU00236, ECO:0000305|PubMed:17344398};
DE   AltName: Full=NAD-dependent protein defatty-acylase sirtuin-2 {ECO:0000305};
DE            EC=2.3.1.- {ECO:0000250|UniProtKB:Q8IXJ6};
DE   AltName: Full=Regulatory protein SIR2 homolog 2;
DE   AltName: Full=SIR2-like protein 2;
GN   Name=Sirt2; Synonyms=Sir2l2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   PROTEIN SEQUENCE OF 6-18; 21-32; 41-116; 176-183; 187-216; 239-245; 302-308
RP   AND 310-332, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain, Hippocampus, and Spinal cord;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Kang S.U.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [3]
RP   INDUCTION.
RX   PubMed=12065666; DOI=10.1046/j.1471-4159.2002.00847.x;
RA   De Smet C., Nishimori H., Furnari F.B., Boegler O., Huang H.-J.S.,
RA   Cavenee W.K.;
RT   "A novel seven transmembrane receptor induced during the early steps of
RT   astrocyte differentiation identified by differential expression.";
RL   J. Neurochem. 81:575-588(2002).
RN   [4]
RP   FUNCTION IN DEACETYLATION OF ALPHA TUBULIN, FUNCTION AS REGULATOR OF
RP   OLIGODENDROCYTE DIFFERENTIATION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY,
RP   AND MUTAGENESIS OF ASN-131; ASP-133 AND HIS-150.
RX   PubMed=17344398; DOI=10.1523/jneurosci.4181-06.2007;
RA   Li W., Zhang B., Tang J., Cao Q., Wu Y., Wu C., Guo J., Ling E.A.,
RA   Liang F.;
RT   "Sirtuin 2, a mammalian homolog of yeast silent information regulator-2
RT   longevity regulator, is an oligodendroglial protein that decelerates cell
RT   differentiation through deacetylating alpha-tubulin.";
RL   J. Neurosci. 27:2606-2616(2007).
RN   [5]
RP   FUNCTION IN REGULATION OF PERIPHERAL MYELINATION, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=21949390; DOI=10.1073/pnas.1104969108;
RA   Beirowski B., Gustin J., Armour S.M., Yamamoto H., Viader A., North B.J.,
RA   Michan S., Baloh R.H., Golden J.P., Schmidt R.E., Sinclair D.A., Auwerx J.,
RA   Milbrandt J.;
RT   "Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through
RT   polarity protein Par-3/atypical protein kinase C (aPKC) signaling.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:E952-961(2011).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16; SER-63; SER-170 AND
RP   SER-330, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [7]
RP   REVIEW, AND FUNCTION AS A TUMOR SUPPRESSOR.
RX   PubMed=22943040;
RA   Park S.H., Zhu Y., Ozden O., Kim H.S., Jiang H., Deng C.X., Gius D.,
RA   Vassilopoulos A.;
RT   "SIRT2 is a tumor suppressor that connects aging, acetylome, cell cycle
RT   signaling, and carcinogenesis.";
RL   Transl. Cancer Res. 1:15-21(2012).
CC   -!- FUNCTION: NAD-dependent protein deacetylase, which deacetylates
CC       internal lysines on histone and alpha-tubulin as well as many other
CC       proteins such as key transcription factors (PubMed:17344398).
CC       Participates in the modulation of multiple and diverse biological
CC       processes such as cell cycle control, genomic integrity, microtubule
CC       dynamics, cell differentiation, metabolic networks, and autophagy.
CC       Plays a major role in the control of cell cycle progression and genomic
CC       stability. Functions in the antephase checkpoint preventing precocious
CC       mitotic entry in response to microtubule stress agents, and hence
CC       allowing proper inheritance of chromosomes. Positively regulates the
CC       anaphase promoting complex/cyclosome (APC/C) ubiquitin ligase complex
CC       activity by deacetylating CDC20 and FZR1, then allowing progression
CC       through mitosis. Associates both with chromatin at transcriptional
CC       start sites (TSSs) and enhancers of active genes. Plays a role in cell
CC       cycle and chromatin compaction through epigenetic modulation of the
CC       regulation of histone H4 'Lys-20' methylation (H4K20me1) during early
CC       mitosis. Specifically deacetylates histone H4 at 'Lys-16' (H4K16ac)
CC       between the G2/M transition and metaphase enabling H4K20me1 deposition
CC       by KMT5A leading to ulterior levels of H4K20me2 and H4K20me3 deposition
CC       throughout cell cycle, and mitotic S-phase progression. Deacetylates
CC       KMT5A modulating KMT5A chromatin localization during the mitotic stress
CC       response. Deacetylates also histone H3 at 'Lys-57' (H3K56ac) during the
CC       mitotic G2/M transition. During oocyte meiosis progression, may
CC       deacetylate histone H4 at 'Lys-16' (H4K16ac) and alpha-tubulin,
CC       regulating spindle assembly and chromosome alignment by influencing
CC       microtubule dynamics and kinetochore function. Deacetylates histone H4
CC       at 'Lys-16' (H4K16ac) at the VEGFA promoter and thereby contributes to
CC       regulate expression of VEGFA, a key regulator of angiogenesis.
CC       Deacetylates alpha-tubulin at 'Lys-40' and hence controls neuronal
CC       motility, oligodendroglial cell arbor projection processes and
CC       proliferation of non-neuronal cells. Phosphorylation at Ser-368 by a
CC       G1/S-specific cyclin E-CDK2 complex inactivates SIRT2-mediated alpha-
CC       tubulin deacetylation, negatively regulating cell adhesion, cell
CC       migration and neurite outgrowth during neuronal differentiation.
CC       Deacetylates PARD3 and participates in the regulation of Schwann cell
CC       peripheral myelination formation during early postnatal development and
CC       during postinjury remyelination. Involved in several cellular metabolic
CC       pathways. Plays a role in the regulation of blood glucose homeostasis
CC       by deacetylating and stabilizing phosphoenolpyruvate carboxykinase PCK1
CC       activity in response to low nutrient availability. Acts as a key
CC       regulator in the pentose phosphate pathway (PPP) by deacetylating and
CC       activating the glucose-6-phosphate G6PD enzyme, and therefore,
CC       stimulates the production of cytosolic NADPH to counteract oxidative
CC       damage. Maintains energy homeostasis in response to nutrient
CC       deprivation as well as energy expenditure by inhibiting adipogenesis
CC       and promoting lipolysis. Attenuates adipocyte differentiation by
CC       deacetylating and promoting FOXO1 interaction to PPARG and subsequent
CC       repression of PPARG-dependent transcriptional activity. Plays a role in
CC       the regulation of lysosome-mediated degradation of protein aggregates
CC       by autophagy in neuronal cells. Deacetylates FOXO1 in response to
CC       oxidative stress or serum deprivation, thereby negatively regulating
CC       FOXO1-mediated autophagy (By similarity). Deacetylates a broad range of
CC       transcription factors and co-regulators regulating target gene
CC       expression. Deacetylates transcriptional factor FOXO3 stimulating the
CC       ubiquitin ligase SCF(SKP2)-mediated FOXO3 ubiquitination and
CC       degradation (By similarity). Deacetylates HIF1A and therefore promotes
CC       HIF1A degradation and inhibition of HIF1A transcriptional activity in
CC       tumor cells in response to hypoxia. Deacetylates RELA in the cytoplasm
CC       inhibiting NF-kappaB-dependent transcription activation upon TNF-alpha
CC       stimulation. Inhibits transcriptional activation by deacetylating
CC       p53/TP53 and EP300. Deacetylates also EIF5A. Functions as a negative
CC       regulator on oxidative stress-tolerance in response to anoxia-
CC       reoxygenation conditions. Plays a role as tumor suppressor
CC       (PubMed:22943040). In addition to protein deacetylase activity, also
CC       has activity toward long-chain fatty acyl groups and mediates protein-
CC       lysine demyristoylation and depalmitoylation of target proteins, such
CC       as ARF6 and KRAS, thereby regulating their association with membranes
CC       (By similarity). {ECO:0000250|UniProtKB:Q8IXJ6,
CC       ECO:0000250|UniProtKB:Q8VDQ8, ECO:0000269|PubMed:17344398,
CC       ECO:0000269|PubMed:21949390, ECO:0000269|PubMed:22943040}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N(6)-acetyl-L-lysyl-[protein] + NAD(+) = 2''-O-acetyl-
CC         ADP-D-ribose + L-lysyl-[protein] + nicotinamide;
CC         Xref=Rhea:RHEA:43636, Rhea:RHEA-COMP:9752, Rhea:RHEA-COMP:10731,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:17154, ChEBI:CHEBI:29969,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:61930, ChEBI:CHEBI:83767;
CC         EC=2.3.1.286; Evidence={ECO:0000255|PROSITE-ProRule:PRU00236,
CC         ECO:0000305|PubMed:17344398};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N(6)-tetradecanoyl-L-lysyl-[protein] + NAD(+) = 2''-O-
CC         tetradecanoyl-ADP-D-ribose + L-lysyl-[protein] + nicotinamide;
CC         Xref=Rhea:RHEA:70567, Rhea:RHEA-COMP:9752, Rhea:RHEA-COMP:15437,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:17154, ChEBI:CHEBI:29969,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:141129, ChEBI:CHEBI:189674;
CC         Evidence={ECO:0000250|UniProtKB:Q8IXJ6};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70568;
CC         Evidence={ECO:0000250|UniProtKB:Q8IXJ6};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N(6)-hexadecanoyl-L-lysyl-[protein] + NAD(+) = 2''-O-
CC         hexadecanoyl-ADP-D-ribose + L-lysyl-[protein] + nicotinamide;
CC         Xref=Rhea:RHEA:70563, Rhea:RHEA-COMP:9752, Rhea:RHEA-COMP:14175,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:17154, ChEBI:CHEBI:29969,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:138936, ChEBI:CHEBI:189673;
CC         Evidence={ECO:0000250|UniProtKB:Q8IXJ6};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70564;
CC         Evidence={ECO:0000250|UniProtKB:Q8IXJ6};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:Q8IXJ6};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250|UniProtKB:Q8IXJ6};
CC   -!- ACTIVITY REGULATION: Inhibited by Sirtinol, A3 and M15 small molecules.
CC       Inhibited by nicotinamide. Inhibited by a macrocyclic peptide inhibitor
CC       S2iL5. Inhibited by EP300-induced acetylation (By similarity).
CC       {ECO:0000250|UniProtKB:Q8IXJ6}.
CC   -!- SUBUNIT: Interacts with CDC20, FOXO3 and FZR1 (By similarity).
CC       Associates with microtubules in primary cortical mature neurons (By
CC       similarity). Homotrimer. Interacts (via both phosphorylated,
CC       unphosphorylated, active or inactive forms) with HDAC6; the interaction
CC       is necessary for the complex to interact with alpha-tubulin, suggesting
CC       that these proteins belong to a large complex that deacetylates the
CC       cytoskeleton. Interacts with FOXO1; the interaction is disrupted upon
CC       serum-starvation or oxidative stress, leading to increased level of
CC       acetylated FOXO1 and induction of autophagy (By similarity). Interacts
CC       with RELA; the interaction occurs in the cytoplasm and is increased in
CC       a TNF-alpha-dependent manner. Interacts with HOXA10; the interaction is
CC       direct. Interacts with YWHAB and YWHAG; the interactions occur in a
CC       AKT-dependent manner and increase SIRT2-dependent TP53 deacetylation.
CC       Interacts with MAPK1/ERK2 and MAPK3/ERK1; the interactions increase
CC       SIRT2 stability and deacetylation activity. Interacts (phosphorylated
CC       form) with KMT5A isoform 2; the interaction is direct, stimulates
CC       KMT5A-mediated methyltransferase activity on histone at 'Lys-20'
CC       (H4K20me1) and is increased in a H(2)O(2)-induced oxidative stress-
CC       dependent manner. Interacts with G6PD; the interaction is enhanced by
CC       H(2)O(2) treatment. Interacts with a G1/S-specific cyclin E-CDK2
CC       complex. Interacts with AURKA, CDK5R1 (p35 form) and CDK5 and HIF1A.
CC       Interacts with the tRNA ligase SARS1; recruited to the VEGFA promoter
CC       via interaction with SARS1 (By similarity). Interacts with BEX4;
CC       negatively regulates alpha-tubulin deacetylation by SIRT2 (By
CC       similarity). {ECO:0000250|UniProtKB:Q8IXJ6,
CC       ECO:0000250|UniProtKB:Q8VDQ8}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q8IXJ6}.
CC       Cytoplasm, perinuclear region {ECO:0000250|UniProtKB:Q8VDQ8}. Cytoplasm
CC       {ECO:0000269|PubMed:17344398}. Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:Q8IXJ6}. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000250|UniProtKB:Q8IXJ6}.
CC       Cytoplasm, cytoskeleton, microtubule organizing center, centrosome,
CC       centriole {ECO:0000250|UniProtKB:Q8IXJ6}. Cytoplasm, cytoskeleton,
CC       spindle {ECO:0000250|UniProtKB:Q8IXJ6}. Midbody
CC       {ECO:0000250|UniProtKB:Q8IXJ6}. Chromosome
CC       {ECO:0000250|UniProtKB:Q8IXJ6}. Perikaryon
CC       {ECO:0000269|PubMed:17344398}. Cell projection
CC       {ECO:0000250|UniProtKB:Q8VDQ8}. Cell projection, growth cone
CC       {ECO:0000250|UniProtKB:Q8VDQ8}. Myelin membrane
CC       {ECO:0000269|PubMed:17344398}. Note=Localizes in the cytoplasm during
CC       most of the cell cycle except in the G2/M transition and during
CC       mitosis, where it is localized in association with chromatin and
CC       induces deacetylation of histone at 'Lys-16' (H4K16ac). Colocalizes
CC       with KMT5A at mitotic foci. Colocalizes with CDK1 at centrosome during
CC       prophase and splindle fibers during metaphase. Colocalizes with Aurora
CC       kinase AURKA at centrosome during early prophase and in the centrioles
CC       and growing mitotic spindle throughout metaphase. Colocalizes with
CC       Aurora kinase AURKB during cytokinesis with the midbody. Colocalizes
CC       with microtubules (By similarity). Detected in perinuclear foci that
CC       may be aggresomes containing misfolded, ubiquitinated proteins (By
CC       similarity). Shuttles between the cytoplasm and the nucleus through the
CC       CRM1 export pathway. Colocalizes with EP300 in the nucleus.
CC       Translocates to the nucleus and chromatin upon bacterium Listeria
CC       monocytogenes infection in interphase cells (By similarity).
CC       Deacetylates FOXO3 in the cytoplasm. Colocalizes with PLP1 in
CC       internodal regions, at paranodal axoglial junction and Schmidt-
CC       Lanterman incisures of myelin sheat. Colocalizes with CDK5R1 in the
CC       perikaryon, neurites and growth cone of hippocampal neurons.
CC       Colocalizes with alpha-tubulin in neuronal growth cone. Localizes in
CC       the cytoplasm and nucleus of germinal vesicle (GV) stage oocytes.
CC       Colocalizes with alpha-tubulin on the meiotic spindle as the oocytes
CC       enter into metaphase, and also during meiotic anaphase and telophase,
CC       especially with the midbody. Colocalizes with PARD3 in internodal
CC       region of axons (By similarity). Colocalizes with acetylated alpha-
CC       tubulin in cell projection processes during primary oligodendrocyte
CC       precursor (OLP) differentiation (By similarity).
CC       {ECO:0000250|UniProtKB:Q8IXJ6, ECO:0000250|UniProtKB:Q8VDQ8}.
CC   -!- TISSUE SPECIFICITY: Expressed in the cerebellum, cerebral cortex and
CC       cervival spinal cord. Expressed in Purkinje cells, oligodendrocytes and
CC       Schwann cells (at protein level). Expressed in the central nervous
CC       system (CNS). {ECO:0000269|PubMed:17344398,
CC       ECO:0000269|PubMed:21949390}.
CC   -!- INDUCTION: In oligodendrocytes during differentiation of CG-4 cells.
CC       {ECO:0000269|PubMed:12065666}.
CC   -!- PTM: Phosphorylated at phosphoserine and phosphothreonine.
CC       Phosphorylated at Ser-330 by a mitotic kinase CDK1/cyclin B at the G2/M
CC       transition; phosphorylation regulates the delay in cell-cycle
CC       progression. Phosphorylated at Ser-330 by a mitotic kinase G1/S-
CC       specific cyclin E/Cdk2 complex; phosphorylation inactivates SIRT2-
CC       mediated alpha-tubulin deacetylation and thereby negatively regulates
CC       cell adhesion, cell migration and neurite outgrowth during neuronal
CC       differentiation. Phosphorylated by cyclin A/Cdk2 and p35-Cdk5 complexes
CC       and to a lesser extent by the cyclin D3/Cdk4 and cyclin B/Cdk1, in
CC       vitro. Dephosphorylated at Ser-330 by CDC14A and CDC14B around early
CC       anaphase (By similarity). {ECO:0000250|UniProtKB:Q8IXJ6}.
CC   -!- PTM: Acetylated by EP300; acetylation leads both to the decreased of
CC       SIRT2-mediated alpha-tubulin deacetylase activity and SIRT2-mediated
CC       down-regulation of TP53 transcriptional activity.
CC       {ECO:0000250|UniProtKB:Q8IXJ6}.
CC   -!- PTM: Ubiquitinated. {ECO:0000250|UniProtKB:Q8IXJ6}.
CC   -!- MISCELLANEOUS: Has some ability to deacetylate histones in vitro, but
CC       seeing its subcellular location, this is unlikely in vivo.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the sirtuin family. Class I subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC086545; AAH86545.1; -; mRNA.
DR   RefSeq; NP_001008369.1; NM_001008368.1.
DR   AlphaFoldDB; Q5RJQ4; -.
DR   SMR; Q5RJQ4; -.
DR   BioGRID; 262752; 2.
DR   IntAct; Q5RJQ4; 1.
DR   MINT; Q5RJQ4; -.
DR   STRING; 10116.ENSRNOP00000069934; -.
DR   ChEMBL; CHEMBL3232690; -.
DR   iPTMnet; Q5RJQ4; -.
DR   PhosphoSitePlus; Q5RJQ4; -.
DR   SwissPalm; Q5RJQ4; -.
DR   jPOST; Q5RJQ4; -.
DR   PaxDb; 10116-ENSRNOP00000059450; -.
DR   Ensembl; ENSRNOT00055057524; ENSRNOP00055047416; ENSRNOG00055033286.
DR   Ensembl; ENSRNOT00060055219; ENSRNOP00060045664; ENSRNOG00060031851.
DR   Ensembl; ENSRNOT00065058483; ENSRNOP00065048132; ENSRNOG00065034052.
DR   UCSC; RGD:621481; rat.
DR   AGR; RGD:621481; -.
DR   RGD; 621481; Sirt2.
DR   VEuPathDB; HostDB:ENSRNOG00000020102; -.
DR   eggNOG; KOG2682; Eukaryota.
DR   HOGENOM; CLU_023643_7_4_1; -.
DR   InParanoid; Q5RJQ4; -.
DR   OrthoDB; 10545at2759; -.
DR   Reactome; R-RNO-2995383; Initiation of Nuclear Envelope (NE) Reformation.
DR   PRO; PR:Q5RJQ4; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000020102; Expressed in testis and 19 other cell types or tissues.
DR   ExpressionAtlas; Q5RJQ4; baseline and differential.
DR   GO; GO:0005814; C:centriole; ISS:UniProtKB.
DR   GO; GO:0005813; C:centrosome; ISS:UniProtKB.
DR   GO; GO:0005694; C:chromosome; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0097386; C:glial cell projection; IDA:UniProtKB.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0030426; C:growth cone; IEA:UniProtKB-SubCell.
DR   GO; GO:0000792; C:heterochromatin; IDA:UniProtKB.
DR   GO; GO:0044224; C:juxtaparanode region of axon; IDA:UniProtKB.
DR   GO; GO:0043219; C:lateral loop; IDA:UniProtKB.
DR   GO; GO:0072687; C:meiotic spindle; ISS:UniProtKB.
DR   GO; GO:0005874; C:microtubule; ISO:RGD.
DR   GO; GO:0030496; C:midbody; ISS:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; ISO:RGD.
DR   GO; GO:0072686; C:mitotic spindle; ISS:UniProtKB.
DR   GO; GO:0043209; C:myelin sheath; IDA:UniProtKB.
DR   GO; GO:0035748; C:myelin sheath abaxonal region; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0033010; C:paranodal junction; IDA:UniProtKB.
DR   GO; GO:0033270; C:paranode region of axon; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043220; C:Schmidt-Lanterman incisure; IDA:UniProtKB.
DR   GO; GO:0005819; C:spindle; ISS:UniProtKB.
DR   GO; GO:0097456; C:terminal loop; IDA:RGD.
DR   GO; GO:0048487; F:beta-tubulin binding; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; ISS:UniProtKB.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0035035; F:histone acetyltransferase binding; ISO:RGD.
DR   GO; GO:0004407; F:histone deacetylase activity; ISS:UniProtKB.
DR   GO; GO:0042826; F:histone deacetylase binding; ISO:RGD.
DR   GO; GO:0003950; F:NAD+ ADP-ribosyltransferase activity; ISO:RGD.
DR   GO; GO:0070403; F:NAD+ binding; ISO:RGD.
DR   GO; GO:0017136; F:NAD-dependent histone deacetylase activity; ISO:RGD.
DR   GO; GO:0046970; F:NAD-dependent histone H4K16 deacetylase activity; ISS:UniProtKB.
DR   GO; GO:0140773; F:NAD-dependent protein demyristoylase activity; ISS:UniProtKB.
DR   GO; GO:0140774; F:NAD-dependent protein depalmitoylase activity; ISS:UniProtKB.
DR   GO; GO:0034979; F:NAD-dependent protein lysine deacetylase activity; IDA:UniProtKB.
DR   GO; GO:0033558; F:protein lysine deacetylase activity; ISS:UniProtKB.
DR   GO; GO:0042903; F:tubulin deacetylase activity; IDA:UniProtKB.
DR   GO; GO:0043130; F:ubiquitin binding; ISO:RGD.
DR   GO; GO:0008270; F:zinc ion binding; ISO:RGD.
DR   GO; GO:0006914; P:autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0044242; P:cellular lipid catabolic process; ISS:UniProtKB.
DR   GO; GO:0061433; P:cellular response to caloric restriction; ISS:UniProtKB.
DR   GO; GO:0071872; P:cellular response to epinephrine stimulus; ISS:UniProtKB.
DR   GO; GO:0071456; P:cellular response to hypoxia; ISS:UniProtKB.
DR   GO; GO:0034599; P:cellular response to oxidative stress; ISS:UniProtKB.
DR   GO; GO:0006325; P:chromatin organization; ISO:RGD.
DR   GO; GO:0040029; P:epigenetic regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0051321; P:meiotic cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0022011; P:myelination in peripheral nervous system; IMP:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0010507; P:negative regulation of autophagy; ISS:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0045599; P:negative regulation of fat cell differentiation; ISS:UniProtKB.
DR   GO; GO:1900226; P:negative regulation of NLRP3 inflammasome complex assembly; ISO:RGD.
DR   GO; GO:0048715; P:negative regulation of oligodendrocyte differentiation; IMP:RGD.
DR   GO; GO:0070446; P:negative regulation of oligodendrocyte progenitor proliferation; IMP:UniProtKB.
DR   GO; GO:0010801; P:negative regulation of peptidyl-threonine phosphorylation; ISS:UniProtKB.
DR   GO; GO:0042177; P:negative regulation of protein catabolic process; ISS:UniProtKB.
DR   GO; GO:2000378; P:negative regulation of reactive oxygen species metabolic process; ISS:UniProtKB.
DR   GO; GO:0045843; P:negative regulation of striated muscle tissue development; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0044546; P:NLRP3 inflammasome complex assembly; ISO:RGD.
DR   GO; GO:0034983; P:peptidyl-lysine deacetylation; ISS:UniProtKB.
DR   GO; GO:0051987; P:positive regulation of attachment of spindle microtubules to kinetochore; ISS:UniProtKB.
DR   GO; GO:0051781; P:positive regulation of cell division; ISS:UniProtKB.
DR   GO; GO:0043388; P:positive regulation of DNA binding; ISS:UniProtKB.
DR   GO; GO:1900119; P:positive regulation of execution phase of apoptosis; ISS:UniProtKB.
DR   GO; GO:0045723; P:positive regulation of fatty acid biosynthetic process; ISO:RGD.
DR   GO; GO:0045836; P:positive regulation of meiotic nuclear division; ISS:UniProtKB.
DR   GO; GO:1900195; P:positive regulation of oocyte maturation; ISS:UniProtKB.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0006476; P:protein deacetylation; IMP:UniProtKB.
DR   GO; GO:0051726; P:regulation of cell cycle; ISS:UniProtKB.
DR   GO; GO:0045598; P:regulation of fat cell differentiation; ISO:RGD.
DR   GO; GO:0031641; P:regulation of myelination; IMP:UniProtKB.
DR   GO; GO:0099149; P:regulation of postsynaptic neurotransmitter receptor internalization; IDA:SynGO.
DR   GO; GO:0042220; P:response to cocaine; IEP:RGD.
DR   GO; GO:0090042; P:tubulin deacetylation; IDA:UniProtKB.
DR   CDD; cd01408; SIRT1; 1.
DR   Gene3D; 3.30.1600.10; SIR2/SIRT2 'Small Domain; 1.
DR   Gene3D; 3.40.50.1220; TPP-binding domain; 1.
DR   InterPro; IPR029035; DHS-like_NAD/FAD-binding_dom.
DR   InterPro; IPR050134; NAD-dep_sirtuin_deacylases.
DR   InterPro; IPR003000; Sirtuin.
DR   InterPro; IPR026591; Sirtuin_cat_small_dom_sf.
DR   InterPro; IPR017328; Sirtuin_class_I.
DR   InterPro; IPR026590; Ssirtuin_cat_dom.
DR   PANTHER; PTHR11085:SF10; NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-2; 1.
DR   PANTHER; PTHR11085; NAD-DEPENDENT PROTEIN DEACYLASE SIRTUIN-5, MITOCHONDRIAL-RELATED; 1.
DR   Pfam; PF02146; SIR2; 1.
DR   PIRSF; PIRSF037938; SIR2_euk; 1.
DR   SUPFAM; SSF52467; DHS-like NAD/FAD-binding domain; 1.
DR   PROSITE; PS50305; SIRTUIN; 1.
PE   1: Evidence at protein level;
KW   Autophagy; Cell cycle; Cell division; Cell membrane; Cell projection;
KW   Chromosome; Cytoplasm; Cytoskeleton; Differentiation;
KW   Direct protein sequencing; Meiosis; Membrane; Metal-binding; Microtubule;
KW   Mitosis; NAD; Neurogenesis; Nucleus; Phosphoprotein; Reference proteome;
KW   Transcription; Transcription regulation; Transferase; Ubl conjugation;
KW   Zinc.
FT   CHAIN           1..350
FT                   /note="NAD-dependent protein deacetylase sirtuin-2"
FT                   /id="PRO_0000244536"
FT   DOMAIN          20..301
FT                   /note="Deacetylase sirtuin-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00236"
FT   REGION          312..350
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           4..14
FT                   /note="Nuclear export signal"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        314..329
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        150
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00236"
FT   BINDING         48..52
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IXJ6"
FT   BINDING         58..60
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IXJ6"
FT   BINDING         130..133
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IXJ6"
FT   BINDING         158
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00236"
FT   BINDING         163
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00236"
FT   BINDING         184
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00236"
FT   BINDING         187
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00236"
FT   BINDING         225..226
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IXJ6"
FT   BINDING         249..251
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IXJ6"
FT   BINDING         287
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IXJ6"
FT   MOD_RES         16
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         63
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         170
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         330
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         334
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IXJ6"
FT   MUTAGEN         131
FT                   /note="N->A: Reduced deacetylase activity on alpha-tubulin
FT                   and stimulates oligodendrocyte precursor (OLP)
FT                   differentiation."
FT                   /evidence="ECO:0000269|PubMed:17344398"
FT   MUTAGEN         133
FT                   /note="D->A: Reduced deacetylase activity on alpha-
FT                   tubulin."
FT                   /evidence="ECO:0000269|PubMed:17344398"
FT   MUTAGEN         150
FT                   /note="H->A: Reduced deacetylase activity on alpha-tubulin
FT                   and stimulates oligodendrocyte precursor (OLP)
FT                   differentiation."
FT                   /evidence="ECO:0000269|PubMed:17344398"
SQ   SEQUENCE   350 AA;  39319 MW;  EA3621A7CCE695FB CRC64;
     MDFLRNLFTQ TLGLGSQKER LLDELTLEGV TRYMQSERCR RVICLVGAGI STSAGIPDFR
     SPSTGLYANL EKYHLPYPEA IFEISYFKKH PEPFFALAKE LYPGQFKPTI CHYFIRLLKE
     KGLLLRCYTQ NIDTLERVAG LEPQDLVEAH GTFYTSHCVN TSCGKEYTMS WMKEKIFSEA
     TPKCEKCQNV VKPDIVFFGE NLPPRFFSCM QSDFSKVDLL IIMGTSLQVQ PFASLISKAP
     LATPRLLINK EKTGQTDPFL GMMMGLGGGM DFDSKKAYRD VAWLGDCDQG CLALADLLGW
     KELEDLVRRE HANIDAQSGS QASNPSATVS PRKSPPPAKE AARTKEKEEH
//
